95 related articles for article (PubMed ID: 3871871)
1. Canine transmissible venereal sarcoma: quantitation of T-lymphocyte subpopulations during progressive growth and spontaneous tumor regression.
Trail PA; Yang TJ
J Natl Cancer Inst; 1985 Feb; 74(2):461-7. PubMed ID: 3871871
[TBL] [Abstract][Full Text] [Related]
2. Tumor infiltrating lymphocytes: CD8+ lymphocytes in canine transmissible venereal sarcomas at different stages of tumor growth.
Barber MR; Yang TJ
Anticancer Res; 1999; 19(2A):1137-42. PubMed ID: 10368665
[TBL] [Abstract][Full Text] [Related]
3. Immunobiology of a spontaneously regressive tumor, the canine transmissible venereal sarcoma (review).
Yang TJ
Anticancer Res; 1988; 8(1):93-5. PubMed ID: 3282476
[TBL] [Abstract][Full Text] [Related]
4. Canine transmissible venereal sarcoma: distribution of T and B lymphocytes in blood, draining lymph nodes and tumours at different stages of growth.
Chandler JP; Yang TJ
Br J Cancer; 1981 Oct; 44(4):514-21. PubMed ID: 6975111
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.
Gillespie GY; Hansen CB; Hoskins RG; Russell SW
J Immunol; 1977 Aug; 119(2):564-70. PubMed ID: 301897
[TBL] [Abstract][Full Text] [Related]
7. Subpopulations of human T-lymphocytes. XIX. T-cells and T-cells with receptors for IgMFc (T mu), IgGFc (T gamma), or IgAFc (T alpha) in the peripheral blood and regional lymph nodes of patients with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Natl Cancer Inst; 1982 Dec; 69(6):1261-4. PubMed ID: 6216359
[TBL] [Abstract][Full Text] [Related]
8. Canine cyclic hematopoiesis: alterations in T lymphocyte subpopulations in peripheral blood, lymph nodes, and thymus of gray collie dogs.
Trail PA; Yang TJ
Clin Immunol Immunopathol; 1986 Nov; 41(2):216-26. PubMed ID: 2945680
[TBL] [Abstract][Full Text] [Related]
9. Sex-related differences in tumor progression associated with altered lymphocyte circulation.
Herman PG; de Sousa M; Schroeder S; Godleski JJ; Lapray JF; Drummey J; Lazarus H
Cancer Res; 1981 Jun; 41(6):2255-61. PubMed ID: 7237425
[TBL] [Abstract][Full Text] [Related]
10. Intralesional Bacillus Calmette-Guérin immunotherapy of canine venereal tumors.
Hess AD; Catchatourian R; Zander AR; Epstein RB
Cancer Res; 1977 Nov; 37(11):3990-4. PubMed ID: 143344
[TBL] [Abstract][Full Text] [Related]
11. Immunoelectron microscopic localization of a tumor-associated antigen (TAA) in the canine transmissible venereal sarcoma by anti-TAA-antiferritin hybrid antibodies.
Hill DL; Yang TJ
J Natl Cancer Inst; 1985 Oct; 75(4):725-32. PubMed ID: 3900513
[TBL] [Abstract][Full Text] [Related]
12. Canine transmissible venereal sarcoma: leukocyte adherence inhibition (LAI) reactivity of various lymphoid tissues of dogs with tumors at different stages of growth.
Harding MW; Yang TJ
Int J Cancer; 1981 Mar; 27(3):349-55. PubMed ID: 7026460
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins.
Bui JD; Uppaluri R; Hsieh CS; Schreiber RD
Cancer Res; 2006 Jul; 66(14):7301-9. PubMed ID: 16849580
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
15. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
[TBL] [Abstract][Full Text] [Related]
16. Regression of feline sarcoma virus-induced sarcomas in dogs. I. Morphologic investigations.
Slauson DO; Osburn BI; Shifrine M; Dungworth DL
J Natl Cancer Inst; 1975 Feb; 54(2):361-70. PubMed ID: 1113321
[TBL] [Abstract][Full Text] [Related]
17. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
Inoue M; Plautz GE; Shu S
Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987
[TBL] [Abstract][Full Text] [Related]
18. Rosette formation of human erythrocytes on canine transmissible venereal sarcoma cells.
Yang TJ; Kennedy JR; Andrews RB
Am J Pathol; 1976 May; 83(2):359-66. PubMed ID: 773193
[TBL] [Abstract][Full Text] [Related]
19. [Infiltrating lymphocytes in esophageal carcinoma--II. Subsets of T lymphocytes].
Wang HF
Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):20-2. PubMed ID: 2942379
[TBL] [Abstract][Full Text] [Related]
20. Role of humoral immunity in progressive and regressive and metastatic growth of the canine transmissible venereal sarcoma.
Fenton MA; Yang TJ
Oncology; 1988; 45(3):210-3. PubMed ID: 3368197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
